Top news of the week: 17.11.2020.

#BioTech #clinicaltrial #biopharma #pneumonia #stocks #analytics #SASusers

Healthcare

On Nov 17, 2020
@BiotechSweden shared
Mispro's Emerging Business Model Helps Biopharma Companies Get to Market Faster https://t.co/x4WOk73A1R https://t.co/T34Ewncz7M
Open

Mispro’s Emerging Business Model Helps Biopharma Companies Get to Market Faster

Mispro’s Emerging Business Model Helps Biopharma Companies Get to Market Faster

This model has the benefit of giving companies direct oversight of their in vivo studies, allowing them to move faster while operationalizing every dollar of their seed financing.

On Nov 11, 2020
@BiotechSweden shared
RT @shanthirex: $FPRX $PFE $BNTX $CODX $VIE and more biotech stocks on the move..... https://t.co/5oNdco2s3e
Open

The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap

The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 10) Amicus Therapeutics, Inc. (...

On Nov 17, 2020
@BiotechSweden shared
5 Biotech Penny Stocks To Watch Right Now After Moderna's Big Update #BioTech via https://t.co/2sI0UxJbpn https://t.co/p04Cs3S6Hg
Open
On Nov 16, 2020
@BiotechSweden shared
B.C. biotech plays key role in vaccine breakthrough #BioTech via https://t.co/2sI0UxJbpn https://t.co/h4yL288bUA
Open

B.C. biotech plays key role in vaccine breakthrough

B.C. biotech plays key role in vaccine breakthrough

Acuitas Therapeutics’ technology helps make Pfizer/BioNTech’s COVID-19 vaccine a reality

On Nov 10, 2020
@JNJInnovation shared
Startups are expected to demonstrate a clear blueprint for CTA approval. Learn more @JLABS #clinicaltrial application program on 24 November https://t.co/56uzp94POc https://t.co/WfrYuEMfOx
Open

Colorize the Blueprint for your Biologics Clinical Trial Application

Colorize the Blueprint for your Biologics Clinical Trial Application

Overview description goes here. If your webinar is a rebroadcast of a recording, please insert/edit this text:*Please note: This webinar will be a rebroadcast of the recording which took ...

On Nov 11, 2020
@SWLifeSciences shared
Biopharma Posts 'Impressive' Q3/20 Sales Amid Pandemic: https://t.co/nZznedbo9Y Paratek Pharmaceuticals' recent and future revenue are discussed in an H.C. Wainwright & Co. report. $PRTK #biopharma #biotech #pneumonia #stocks Paratek Pharmaceuticals @ParatekPharma https://t.co/8ZctP55uvR
Open

Biopharma Posts 'Impressive' Q3/20 Sales Amid Pandemic Research Report

Biopharma Posts 'Impressive' Q3/20 Sales Amid Pandemic Research Report

Paratek Pharmaceuticals' recent and future revenue are discussed in an H.C. Wainwright & Co. report.

On Nov 12, 2020
@mlambrecht shared
RT @SAS_Cares: The @SASsoftware Health portfolio provides industry-leading #analytics solutions to small biotech entities just getting started in clinical development as well as global pharmaceutical enterprises. Learn more 👉#SASusers https://t.co/3BTrFHwV8l
Open

SAS analytics power life-saving drug and vaccine development

SAS analytics power life-saving drug and vaccine development

Supporting clinical-trial modernization is the updated SAS® Life Science Analytics Framework, which helps transform data into life-changing insights and deliver better, safer therapies to ...

On Nov 16, 2020
@BiotechSweden shared
Moderna, the small biotech company taking on the pandemic #BioTech via https://t.co/2sI0UxJbpn https://t.co/6WeyOzvpwg
Open

With new vaccine technology, small biotech firm Moderna battles mighty pandemic

With new vaccine technology, small biotech firm Moderna battles mighty pandemic

Massachusetts-based company saw share price soar after announcing its coronavirus vaccine is 94.5% effective. Bullish CEO, promising up to a billion doses, says it's just the start